Who owns AMRYT PHARMA LTD - SPNR ADR?
- CUSIP Number: 03217l106
Tip: Access positions for across all investors
Analyze quarterly positions in Amryt Pharma Ltd - Spnr with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Amryt Pharma Ltd - Spnr stock
Who bought or sold AMRYT PHARMA LTD - SPNR ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citigroup | 35k | $515k | 100% | Mar 2023 |
|
Who sold out of Amryt Pharma Ltd - Spnr?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Athyrium Capital Management | Mar 2023 | 8.9M | $129M |
| Highbridge Capital Management | Mar 2023 | 6.3M | $92M |
| Stonepine Capital Management | Mar 2023 | 6.3M | $92M |
| Balyasny Asset Management | Mar 2023 | 5.0M | $73M |
| MPM Asset Management | Mar 2023 | 2.7M | $39M |
| Pentwater Capital Management | Mar 2023 | 2.5M | $37M |
| UBS O'Connor | Mar 2023 | 2.0M | $29M |
| TIG Advisors | Mar 2023 | 1.7M | $24M |
| Alpine Associates Management | Mar 2023 | 1.6M | $23M |
| Rock Springs Capital Management | Mar 2023 | 1.3M | $19M |
| Glazer Capital | Mar 2023 | 830k | $12M |
| Nantahala Capital Management | Mar 2023 | 821k | $12M |
| Centiva Capital | Mar 2023 | 790k | $12M |
| Black Maple Capital Management | Mar 2023 | 746k | $11M |
| Clearline Capital | Mar 2023 | 630k | $9.2M |
| CSS | Mar 2023 | 629k | $9.2M |
| Barclays | Mar 2023 | 610k | $8.9M |
| Water Island Capital | Mar 2023 | 585k | $8.5M |
| Hudson Bay Capital Management | Mar 2023 | 493k | $7.2M |
| Handelsbanken Fonder AB | Mar 2023 | 525k | $7.7M |
| Tudor Investment Corporation | Mar 2023 | 489k | $7.1M |
| Whitebox Advisors | Mar 2023 | 467k | $6.8M |
| New Leaf Venture Partners | Mar 2023 | 450k | $6.6M |
| LMR Partners | Mar 2023 | 400k | $5.8M |
| Millennium Management | Mar 2023 | 380k | $5.5M |
| Bank of America Corporation | Mar 2023 | 365k | $5.3M |
| Qube Research & Technologies | Mar 2023 | 324k | $4.7M |
| Equitec Proprietary Markets | Mar 2023 | 316k | $4.6M |
| Samsara BioCapital | Mar 2023 | 305k | $4.4M |
| Wells Fargo & Company | Dec 2022 | 293k | $2.1M |
| Syquant Capital Sas | Mar 2023 | 258k | $3.8M |
| Capula Management | Mar 2023 | 247k | $3.6M |
| Yakira Capital Management | Mar 2023 | 210k | $3.1M |
| Fifth Lane Capital | Mar 2023 | 190k | $2.8M |
| Natixis | Mar 2023 | 190k | $2.8M |
| Jane Street | Mar 2023 | 177k | $2.6M |
| Gabelli Funds | Mar 2023 | 168k | $2.5M |
| Goldman Sachs Group | Mar 2023 | 164k | $2.4M |
| Anqa Management | Mar 2023 | 157k | $2.3M |
| Harvest Management | Mar 2023 | 150k | $2.2M |
| Tejara Capital | Mar 2023 | 121k | $1.8M |
| Gabelli Securities | Mar 2023 | 115k | $1.7M |
| Privium Fund Management | Mar 2023 | 104k | $1.5M |
| Bank Of Montreal | Dec 2022 | 102k | $769k |
| Cinctive Capital Management | Mar 2023 | 100k | $1.5M |
| Renaissance Technologies | Mar 2023 | 99k | $1.4M |
| PenderFund Capital Management | Mar 2023 | 95k | $1.9M |
| Quinn Opportunity Partners | Mar 2023 | 86k | $1.3M |
| Morgan Stanley | Dec 2022 | 83k | $607k |
| Cantor Fitzgerald, L. P. | Mar 2023 | 82k | $1.2M |
| AlphaCentric Advisors | Mar 2023 | 81k | $1.2M |
| JBF Capital | Mar 2023 | 75k | $1.1M |
| Vestcor Investment Management Corp | Mar 2023 | 70k | $1.0M |
| Arrowstreet Capital, Limited Partnership | Mar 2023 | 65k | $940k |
| Advisor Group Holdings | Mar 2023 | 55k | $794k |
| Ameriprise Financial | Mar 2023 | 45k | $657k |